Course outline
This two-day intensive course will update pharmaceutical and medical device professionals with the latest global regulations governing clean room standards, guidance and regulations. They will also learn practical strategies to ensure compliance to those regulations and be able to discuss challenges and questions they currently have in the area.
Day 1 |
Facts, figures, references |
|
Current PIC/s code of GMP, 16th August 2002, Annex 1 |
|
PIC/s Annex 1 – Essential features |
|
US FDA guidance vs PIC/s guidance – The essential differences |
|
Update on China’s SFDA GMP publication and implementation plans. |
|
China SFDA Sterile Products GMP Annex intentions. |
Day 2 |
The role and update of ISO 14644-1 & 2 in the context of the sterile GMPs. |
|
Status and review of PIC/s PI 032-1 1 December 2009 “Recommendation – GMP Annex 1 Revision 2008, interpretation of the most important changes for the manufacture of sterile medicinal products”. |
|
Workshop sessions
|
|
Current hot topics:
|
|
Questions and discussions - Gordon has a talent for distilling complex issues and concepts into plain English. This, combined with his depth of technical knowledge and practical experience, allows him to provide expert analysis of issues that you may be facing. |
Perth
Date: 11-12th Feb 2010
Time: 9 am to 4:30 pm
Venue: Burswood on Swan, 1 Camfield Drive, Burswood
Sydney
Date: 15-16th Feb, 2010
Time: 9 am to 4:30 pm
Venue: Eden Gardens, Cnr Lane Cove Fontenoy Rd, North Ryde
Melbourne
Date: 18-19th Feb 2010
Time: 9 am to 4:30 pm
Venue: Bruce County Hotel, 445 Blackburn Rd, Mt Waverley
The cost for the 2 day course is $980 + GST per person. This includes lunch and refreshments.
PharmOut's Gordon Farquharson is widely recognised as a world leader and expert in sterile products manufacture, clean room design and maintenance and utilities for the same.
Gordon is the Chair of British, CEN and ISO committees responsible for development and deployment of the ISO 14644 family of cleanroom standards.
He is also an advisor to the EMeA concerning the revision to Annex 1 of the EU GMP in February 2008 and a member of the WHO expert committee (WHO Pharmaceutical Water GMP; Sterile GMP Annex 1).
His experience includes years at the coal face of pharmaceutical and medical device manufacture, with strong experience in processes, facilities, and critical utilities. He has held senior roles in the fields of design, construction, quality & safety management, validation and regulatory compliance.
His area of interest is the conversion of GMP principles and philosophies into a reliable operational assets. His technical expertise is associated with the controlled environment and critical utilities for product manufacture and safety critical systems.
Gordon has also conducted a broad spectrum of international audits, inspections, and training assignments; encompassing technical aspects, GMP compliance, and operational due diligence.
Training attendees should include:
![]()

